China will rely on a vaccine produced in the European Union to immunize part of its population against Covid-19, after its health authorities have also had to acknowledge that Chinese vaccines are less effective than Western ones. According to the Wall Street Journal, Beijing is expected to approve the German BioNTech vaccine before July, even if the calendar would be subject to political choices (the Chinese government would like its vaccines to be placed on the WHO emergency list first). Gao Fu, the head of the Center for Disease Control and Prevention, backtracked halfway after saying that Chinese vaccines “don’t achieve very high protection rates.” But propaganda and censorship can do nothing against the data collected where China has exported Sinopharm or Sinovac.
Subscribe to continue reading
Are you already a subscriber? Log inStay informed wherever you are thanks to our digital offer
The inquiries, the editorials, the newsletters. The major current events on the devices you prefer, daily insights from Italy and the world
The web sheet at € 8.00 for one month Discover all the solutions
